Vitiello, P.P.; Valsecchi, A.A.; Duregon, E.; Di Celle, P.F.; Cassoni, P.; Papotti, M.; Bardelli, A.; Di Maio, M.
KRAS G12C Inhibition in Solid Tumors: Biological Breakthroughs, Clinical Evidence, and Open Challenges. Cancers 2025, 17, 2803.
https://doi.org/10.3390/cancers17172803
AMA Style
Vitiello PP, Valsecchi AA, Duregon E, Di Celle PF, Cassoni P, Papotti M, Bardelli A, Di Maio M.
KRAS G12C Inhibition in Solid Tumors: Biological Breakthroughs, Clinical Evidence, and Open Challenges. Cancers. 2025; 17(17):2803.
https://doi.org/10.3390/cancers17172803
Chicago/Turabian Style
Vitiello, Pietro Paolo, Anna Amela Valsecchi, Eleonora Duregon, Paola Francia Di Celle, Paola Cassoni, Mauro Papotti, Alberto Bardelli, and Massimo Di Maio.
2025. "KRAS G12C Inhibition in Solid Tumors: Biological Breakthroughs, Clinical Evidence, and Open Challenges" Cancers 17, no. 17: 2803.
https://doi.org/10.3390/cancers17172803
APA Style
Vitiello, P. P., Valsecchi, A. A., Duregon, E., Di Celle, P. F., Cassoni, P., Papotti, M., Bardelli, A., & Di Maio, M.
(2025). KRAS G12C Inhibition in Solid Tumors: Biological Breakthroughs, Clinical Evidence, and Open Challenges. Cancers, 17(17), 2803.
https://doi.org/10.3390/cancers17172803